Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

62.76 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
45 46 Next >
Deadline Approaching: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith
From Law Offices of Howard G. Smith
Via Business Wire
Great News for Hims & Hers Stock Investors
Via The Motley Fool
Class Action Announcement HIMS: A Securities Fraud Class Action Lawsuit Was Filed Against Hims & Hers Health, Inc. (HIMS)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Class Action Announcement HIMS: A Securities Fraud Class Action Lawsuit Was Filed Against Hims &amp; Hers Health, Inc. (HIMS)
Via TheNewswire.com
Topics Fraud Lawsuit
Circle Internet, Hims & Hers Health And CoreWeave Are Among Top 10 Large Cap Losers Last Week (June 23-27): Are The Others In Your Portfolio?
Last week's worst performers include CRCL, HIMS, VG, QXO, CRWV, DUOL, EQIX, EQNR, CF, and EC. Are they in your portfolio? 
Via Benzinga
HIMS Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (HIMS) - Contact Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
HIMS Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims &amp; Hers Health, Inc. (HIMS) - Contact Kessler Topaz Meltzer &amp; Check, LLP
Via TheNewswire.com
Topics Fraud Lawsuit
HIMS Investor Notice: Robbins LLP Reminds Hims & Hers Health, Inc. Stockholders of the Class Action Against the Company
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
HIMS Investor Notice: Robbins LLP Reminds Hims &amp; Hers Health, Inc. Stockholders of the Class Action Against the Company
Via TheNewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMS
From Pomerantz LLP
Via GlobeNewswire
HIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
From Faruqi & Faruqi LLP
Via GlobeNewswire
Benzinga Bulls And Bears: Nvidia, Micron, HIMS — And Markets Soar On Mideast And Tariff Relief
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Hims & Hers Stock Investors Need to Know This Before Buying or Selling This Growth Stock
Via The Motley Fool
Hims & Hers Stock Financial Analysis Following Huge Stock Price Crash
Via The Motley Fool
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) to Contact the Firm Before Lead Plaintiff Deadline on August 25, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Kaplan Fox Encourages Investors of Hims &amp; Hers Health, Inc. (HIMS) to Contact the Firm Before Lead Plaintiff Deadline on August 25, 2025
Via TheNewswire.com
Topics Lawsuit
HIMS DEADLINE NOTICE: Hims & Hers Health, Inc. Investors that Suffered Losses are Notified of the August 25 Class Action Deadline -- Contact BFA Law
Via ACCESS Newswire
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
From Glancy Prongay & Murray LLP
Via Business Wire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
From The Rosen Law Firm PA
Via GlobeNewswire
Stocks making big moves this week: Torrid, Provident Financial Services, Bumble, Coinbase, and Hims & Hers Health
Check out the companies making headlines this week: 
Via StockStory
Topics Workforce
HIMS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?
The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies. 
Via The Motley Fool
Topics Intellectual Property
Massive News for Hims & Hers Stock Investors!
Via The Motley Fool
Down Over 30%, What's Going on With Hims & Hers stock?
Via The Motley Fool
Shareholder Alert: Robbins LLP Informs Investors of the Hims & Hers Health, Inc. Class Action
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Shareholder Alert: Robbins LLP Informs Investors of the Hims &amp; Hers Health, Inc. Class Action
Via TheNewswire.com
2 Volatile Stocks Worth Your Attention and 1 to Turn Down
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
This Weight Loss Partnership Was a Short One
Via The Motley Fool
Topics Economy
Hims & Hers Health, Inc. (NYSE: HIMS) Accused of “Illegal Mass Compounding and Deceptive Marketing” Practices; Investors Urged to Contact Award-Winning Firm, Gibbs Mura
From Gibbs Mura
Via Business Wire
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.